Ending the HIV Epidemic: Persistence on ART

11/14/22 • 20 min

In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discusses strategies for and importance of HIV care engagement and reengagement for those who have fallen out of care. Her overview includes:

WHO Global Health Strategy on HIV
Longitudinal HIV care trajectories
Promotion of successful care and antiretroviral therapy (ART) adherence
Differentiated service delivery
Improving care and ART adherence in high-risk groups
Patient perspectives on ART persistence

Presenter:
Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Director
Desmond Tutu HIV Centre
Past President
International AIDS Society
Faculty of Health Sciences
University of Cape Town
Cape Town, South Africa

Panelists:
Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD
Chief and Director
VHS-Infectious Diseases Medical Centre
Director
Chennai Antiviral Research and Treatment (CART) Clinical Research Site
Voluntary Health Services
Chennai, India

Chloe Orkin, MBChB, FRCP, MD
Professor of HIV
Queen Mary, University of London
Consultant Physician
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom

Babafemi Taiwo, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Feinberg School of Medicine
Chicago, Illinois

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Follow along with the slides:
https://bit.ly/3dSNoum

Link to full program:
https://bit.ly/3AE2AV1

WHO Global Health Strategy on HIV
Longitudinal HIV care trajectories
Promotion of successful care and antiretroviral therapy (ART) adherence
Differentiated service delivery
Improving care and ART adherence in high-risk groups
Patient perspectives on ART persistence

Babafemi Taiwo, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Feinberg School of Medicine
Chicago, Illinois

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Follow along with the slides:
https://bit.ly/3dSNoum

Link to full program:
https://bit.ly/3AE2AV1

Previous Episode

Treatment Barriers in Asian Communities in the US

This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US.” First, Melinda Tran discusses treatment and retention of HBV care in Asian Communities in the US with Jennifer Wild, MS, BSN, RN, OCN, and Thuan Vu, MD. Their conversation offers an interesting mix of insights from the point of view of patient advocates and healthcare providers.

Topics include barriers to treatment—like a lack of insurance coverage and financial support, complexities in treatment guidelines, psychosocial factors—and addressing practical solutions to these barriers.

Link to full program
http://bit.ly/3Gf7NWo

Next Episode

Cutting-Edge Concepts in HIV Care: PrEP

In this episode, Paul E. Sax, MD, discusses the latest recommendations and options for HIV pre-exposure prophylaxis (PrEP), including:

CDC PrEP guideline 2021 updates for oral PrEP
The ANRS IPERGAY study: on-demand oral emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) PrEP in men who have sex with men who are at high risk for HIV infection
A review of the HPTN 083 and 084 studies: efficacy and safety of long-acting (LA) injectable cabotegravir (CAB) vs daily oral FTC/TDF for PrEP
1-year follow-up after unblinding for HPTN 083 and 084
LA CAB for PrEP: monitoring and safety
Stopping LA CAB for PrEP

Presenter:

Paul E. Sax, MD
Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Link to full program:
https://bit.ly/3VIsDTg

Follow along with the slides at:
https://bit.ly/3Gh9AKG